摘要
超声微泡造影剂作为药物运载体使一种新型的疾病靶向治疗策略,具有靶向性、器官组织特异性的优点。虽然尚未在临床中得以应用,但近年来,在疾病的靶向治疗中取得了长足的进步,表现出极有潜力的临床应用前景。本文旨在对其最新研究进展进行综述。
Ultrasound microcapsular contrast agent as a drug transporter is a new type of disease targeted treatment strategies, with the advantages of targeting the advantages of organ, tissue specificity, etc. Though it has not be applied in clinical practice, but in recent years the targeted therapy of the disease has got great strides, showing very promising prospects for clinical application. This article aims to summarize the recent progress.
出处
《药品评价》
CAS
2012年第24期29-32,共4页
Drug Evaluation
关键词
超声微泡造影剂
靶向治疗
进展
Ultrasound microcapsular contrast agent
Targeted therapy
Progress
